Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mammary Neoplasms, Human”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07427394
What this trial is testing

Study to Evaluate the Safety and Tolerability of Camizestrant in Combination With Atirmociclib in Women With Advanced Breast Cancer

Who this might be right for
Advanced Breast Cancer
AstraZeneca 24
Not applicableAvailableNCT04091295
What this trial is testing

BLESSED: Expanded Access for DNG64-CAR-V for Advanced Pancreatic Cancer, Sarcoma and Carcinoma of Breast

Who this might be right for
Pancreatic CancerOsteosarcomaMPNST (Malignant Peripheral Nerve Sheath Tumor)+6 more
Aveni Foundation
Not applicableStudy completedNCT02954471
What this trial is testing

Study of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Participants With Early/Metastatic Breast Cancer in Saudi Arabia

Who this might be right for
Breast Cancer
Hoffmann-La Roche 351
Not applicableStudy completedNCT02921191
What this trial is testing

Descriptive Analysis of G-CSF Use in Patients With Breast Cancer, Lung Cancer, or Lymphoma Treated

Who this might be right for
Breast CancerLung Cancer
Biologics & Biosimilars Collective Intelligence Consortium 57,725
Testing effectiveness (Phase 2)Active Not RecruitingNCT05565417
What this trial is testing

Study of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or Lymphomas

Who this might be right for
Non Small Cell Lung CancerHead and Neck Squamous Cell CarcinomaTriple Negative Breast Cancer+9 more
Immunitas Therapeutics 67
Not applicableUnknownNCT02876497
What this trial is testing

Study of Trans-tissular Migration of Macrophages Associated to Human Breast Cancer

Who this might be right for
Breast Cancer
Institut Claudius Regaud 200
Not applicableStudy completedNCT04671615
What this trial is testing

Understand the Treatment Patterns and Patients and Their Clinical Outcomes Who Are Taking Palbociclib in a Real Life Setting in Israel.

Who this might be right for
Metastatic Breast Cancer
Pfizer 559
Testing effectiveness (Phase 2)Study completedNCT01173497
What this trial is testing

A Study Evaluating INIPARIB in Combination With Chemotherapy to Treat Triple Negative Breast Cancer Brain Metastasis

Who this might be right for
Estrogen Receptor Negative (ER-Negative) Breast CancerProgesterone Receptor Negative (PR-Negative) Breast CancerHuman Epidermal Growth Factor Receptor 2 Negative (HER2-Negative) Breast Cancer+1 more
Sanofi 44
Testing effectiveness (Phase 2)Study completedNCT01240720
What this trial is testing

A Dose Finding and Efficacy Study of the Tumour Targeting Human 131I-F16SIP Monoclonal Antibody in Patients With Cancer

Who this might be right for
Cancer
Philogen S.p.A. 65
Early research (Phase 1)Active Not RecruitingNCT04288089
What this trial is testing

H3B-6545 in Combination With Palbociclib in Women With Advanced or Metastatic Estrogen Receptor-Positive Human Epidermal Growth Factor Receptor-2 (HER2)-Negative Breast Cancer

Who this might be right for
Receptors, EstrogenGenes, Erbb-2Breast Neoplasms
Eisai Inc. 31
Testing effectiveness (Phase 2)Study completedNCT05963997
What this trial is testing

Samuraciclib and Elacestrant in Participants With Metastatic or Locally Advanced HR+/HER2-negative Breast Cancer

Who this might be right for
Metastatic Breast CancerLocally Advanced Breast CancerBreast Cancer
Carrick Therapeutics Limited 49
Not applicableStudy completedNCT05364450
What this trial is testing

Facilitating Adaptive Coping With Fear of Recurrence Among Breast Cancer Survivors

Who this might be right for
Breast NeoplasmBreast CancerBreast Carcinoma+9 more
Indiana University 390
Not applicableUnknownNCT05781633
What this trial is testing

The Efficacy and Safety of Eutideron, Etoposide, and Bevacizumab in Patients With Brain Metastases From Breast Cancer.

Who this might be right for
Mammary Neoplasms, Human
Tianjin Medical University Cancer Institute and Hospital 43
Very early researchActive Not RecruitingNCT03164486
What this trial is testing

First-in-Human Positron Emission Tomography Study Using the 18F-αvβ6-Binding-Peptide

Who this might be right for
Breast CarcinomaColorectal CarcinomaLung Carcinoma+5 more
Julie L. Sutcliffe, Ph.D 27
Not applicableActive Not RecruitingNCT03904173
What this trial is testing

Establishment of Molecular Profiling for Individual Clinical Routine Treatment Decision in Early Breast Cancer

Who this might be right for
Breast CancerBreast NeoplasmsHormone Receptor Positive Tumor
Oslo University Hospital 2,300
Early research (Phase 1)Study completedNCT01288261
What this trial is testing

Paclitaxel and Bavituximab in Treating Patients With HER2-Negative Metastatic Breast Cancer

Who this might be right for
Human Epidermal Growth Factor 2 Negative Carcinoma of BreastMale Breast CancerRecurrent Breast Cancer+2 more
University of Arizona 14
Testing effectiveness (Phase 2)Ended earlyNCT00679029
What this trial is testing

Chemotherapy & Bevacizumab for Human Epidermal Growth Factor Receptor 2 (HER2)/Neu-Negative Stage II/III Breast Cancer

Who this might be right for
HER2-negative Breast CancerStage II Breast CancerStage IIIA Breast Cancer+2 more
University of Nebraska 15
Early research (Phase 1)Ended earlyNCT06052852
What this trial is testing

Study of BDC-3042 as Single Agent and in Combination With Cemiplimab in Patients With Advanced Malignancies

Who this might be right for
Triple Negative Breast CancerClear Cell Renal Cell CarcinomaOvarian Cancer+4 more
Bolt Biotherapeutics, Inc. 17
Testing effectiveness (Phase 2)Study completedNCT02132949
What this trial is testing

A Study Evaluating Pertuzumab (Perjeta) Combined With Trastuzumab (Herceptin) and Standard Anthracycline-based Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced, Inflammatory, or Early-stage Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 401
Not applicableLooking for participantsNCT00034216
What this trial is testing

Collection of Blood From Patients With Cancer

Who this might be right for
Prostate CancerBreast CancerColon Cancer+2 more
National Cancer Institute (NCI) 1,750
Next Page